← All patents

US12178848B2

Methods and compositions for the treatment of exocrine pancreatic insufficiency

University of Texas System

Abstract

The present invention relates to the treatment of secretory disorders, and provides novel methods of treatment of these disorders comprising the administration of fibroblast growth factor 21 (FGF21) or derivatives thereof. The methods of the invention are useful in conditions including exocrine …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
David J. Mangelsdorf
Priority date
May 25, 2016
Filing date
March 11, 2022
Grant date
December 31, 2024
Publication date
December 31, 2024
Language
en
Metadata fetched
August 29, 2026 00:32